🧫
Sex differences in CB1R-mediated cannabinoid analgesia in neuropathic pain
active
experiment
Created: 2026-04-11T00:49:10
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-8ad644d2-5765-4323-8c44-563410be923e
🧫 Experiment Protocol
Validationneuropathic painCNR1,CAMK2A,GAD2,SLC17A6C57BL/6J mice (8-12 weeks old), GAD2-Cre-tdTomato mice, CB1R-floxed mice, CB1R-iCre-EGFP miceproposed
This study investigated sex-specific mechanisms of cannabinoid analgesia in neuropathic pain using a chronic constriction injury (CCI) model. The researchers examined the role of cannabinoid receptor 1 (CB1R) expressed on CaMKIIα neurons in the medial prefrontal cortex (mPFC) and their projections to the ventrolateral periaqueductal gray (vlPAG). Using viral tracing, immunohistochemistry, fluorescent in situ hybridization, RNAscope, conditional knockout, opto-XR, and electrophysiology approaches, they mapped CB1R expression patterns and investigated functional significance. The study focused on the mPFC-vlPAG circuit's role in descending pain inhibition and how CB1R deletion in this pathway affects pain sensitivity differently in male and female mice. The research revealed that deleting CB1R in the mPFCCaMKIIα-vlPAGGABA pathway causes severe pain in female mice and diminishes vlPAGvGlut2 inhibition, providing mechanistic insights into sex-specific cannabinoid analgesia.
PRIMARY OUTCOME
Sex-specific differences in cannabinoid-induced analgesia and mechanical allodynia
EXPECTED OUTCOMES
Female mice show superior analgesic responses to cannabinoids compared to males; CB1R deletion in mPFC-vlPAG pathway causes more severe pain in females; circuit-specific sex differences in synaptic plasticity and neurotransmitter release
SUCCESS CRITERIA
Demonstration of sex-specific differences in cannabinoid analgesia, identification of CB1R expression patterns, functional validation of mPFC-vlPAG circuit role
PROTOCOL
Chronic constriction injury (CCI) model of sciatic nerve using 6-0 chromic gut sutures, viral tracing, immunohistochemistry, fluorescent in situ hybridization, RNAscope, conditional knockout, optogenetics, electrophysiology, behavioral pain testing
LINKED HYPOTHESES
Source: PMID 41380094 ↗
🧫 Experiment Extras
PATHWAY
endocannabinoid signaling, descending pain inhibition, GABAergic neurotransmission
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.